Cross-border converter
DB07 211000 → CAE Rev 4 equivalent (Portugal)
Denmark's national activity classification (DB07) shares its 4-digit backbone with the EU NACE Rev 2.1 standard. We use that backbone to surface the equivalent CAE Rev 4 subclass(es) used in Portugal.
Shared EU parent
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
211000
Fremstilling af farmaceutiske råvarer
Branchen omfatter fremstilling af farmaceutiske råvarer til brug i fx lægemidler. Branchen omfatter også forarbejdning af blod, fremstilling af kemisk rent sukker og forarbejdning af kirtler.
21100
Fabricação de produtos farmacêuticos de base
Compreende a fabricação de produtos de origem natural ou sintética, obtidos por processo químico ou biológico, para uso farmacêutico tais como: ácidos salicílicos e os acetilsalicílicos; sulfamidas ou sulfonamidas; açúcares quimicamente puros; vitaminas e provitaminas; hormonas e esteróides; heteróxidos; alcalóides vegetais, naturais e sintéticos; antibióticos; glândulas, extratos de glândulas ou de outros órgãos ou das suas secreções; toxinas, culturas de microrganismos e produtos semelhantes.
About this conversion
DB07 is the activity classification used in Denmark. CAE Rev 4 is the equivalent system in Portugal. Both are national implementations of EU NACE Rev 2.1, so any 5th-digit subclass in one system can be traced back to a shared 4-digit EU class — and from there, forward into the other country's subclasses.
This page is generated for the query "DB07 211000 to CAE Rev 4" and stays in sync with our monthly Market Intelligence sync.